Risk Factors Associated with Acquisition of ESBL Escherichia Coli Infection, Detection and Treatment, a Case Report
Keywords:
ESBL, escherichia coli, CLSI, MIC method, PICC line cephalosporinsand ertapenem
Abstract
ESBL group of organisms are beta lactamase enzyme producing organisms capable of breaking the beta lactam ring in antibiotics hence are resistant to usually cephalosporins and few other antibiotics. In these E.coli is the most common bacteria that lives in gut harmlessly but causes Urinary tract infection and in severe cases blood poisoning, septicemia or bacteremia leading to serious sepsis. When not treated it leads to inflammation of body parts, blood clots, blocking oxygen supply and ultimately causing death. In present study report a 51 years old Indian tourist patient was admitted in a Wake Med Health hospital at USA, with symptoms of UTI.In hospital she was diagnosed with ESBL E.coliUTI infection withgt;100,000 colonies /ml and blood culture showed positive result. In this case the Sepsiswas resulted as secondary infection. She even suffered with chronic anemia. The previous medical history of subject showed several risk factors for acquisition of infection. These include elder age, female gender,chronic anemia, recent hospitalization, surgical procedure (due to hysterectomy), intravenous catheterization, intensive careand prolonged usage of high potency antibiotics.All these factors are established as predictive and prognostic risk factors for acquisition of infection and also results in colonization of organism.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2014-03-15
Issue
Section
License
Copyright (c) 2014 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.